• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕罗蒙库特科劳医院糖尿病混合饮食与市售糖尿病饮食对2型糖尿病持续管饲患者血糖变异性的比较研究。

Comparative study between the Phramongkutklao's diabetic blenderized diets and commercial diabetic diets on glycemic variability in continuous tube fed patients with type 2 diabetes.

作者信息

Tiyapanjanit Teeranun, Boonyavarakul Apussanee

出版信息

J Med Assoc Thai. 2014 Nov;97(11):1151-6.

PMID:25675679
Abstract

BACKGROUND

Rapid glucose fluctuations over daily period play an important role on diabetic complications.

OBJECTIVE

To compare glycemic variability, mean plasma glucose, number ofcapillary blood glucose tests, and cost between the Phramongkutklao's diabetic formula and commercial diabetic formula in continuous tube fed patients with stable condition in type 2 diabetes.

MATERIAL AND METHOD

A cross-over design study was performed between October 2010 and February 2011 in the medical department in Phramongkutklao Hospital. The researchers enrolled type 2 diabetic patients with stable condition who were on continuous tube fed. Seventy-two-hour continuous subcutaneous glucose monitoring was performed in all patients. Comparison ofmean amplitude ofglycemic excursions (MAGE), mean plasma glucose, cost, and number of capillary blood glucose tests were analyzed by using non-parametric Wilcoxon signed-rank test. Significance was defined as p<0.05. Results: Ten subjects were included in the present study. The Phramongkutklao's Diabetic Formula resulted in significantly lower mean plasma glucose (122±26.25 vs. 144.68±36.91 mg/dL, p = 0.022), cost (550.1±33.57 vs. 797.81±42.29 baht, p = 0.004), and number of capillary blood glucose tests (5±0.94 vs. 5.3±0.82 times, p = 0.083) when compared with commercial diabetic formula, but no significant difference in MAGE level (5.86±2.78 vs. 7.71±4.34 mg/dL, p = 0.333).

CONCLUSION

The Phramongkutklao's diabetic formula has significantly lower mean plasma glucose, less number of capillary blood glucose tests, and is less expensive than commercial diabetic formula. The glucose variability (MAGE) of the Phramongkutklao diabetic formula has also less than commercial diabetic formula, but does not reach statistical significance. The level ofplasma glucose was lower than 180 mg/dL in both formulas.

摘要

背景

每日快速的血糖波动在糖尿病并发症中起重要作用。

目的

比较在2型糖尿病病情稳定的持续管饲患者中,诗里蒙坤贴医院糖尿病配方与市售糖尿病配方在血糖变异性、平均血浆葡萄糖、毛细血管血糖检测次数及成本方面的差异。

材料与方法

2010年10月至2011年2月在诗里蒙坤贴医院内科进行了一项交叉设计研究。研究人员纳入了病情稳定的持续管饲2型糖尿病患者。对所有患者进行了72小时的持续皮下血糖监测。采用非参数Wilcoxon符号秩检验分析血糖波动平均幅度(MAGE)、平均血浆葡萄糖、成本及毛细血管血糖检测次数的差异。显著性定义为p<0.05。结果:本研究纳入了10名受试者。与市售糖尿病配方相比,诗里蒙坤贴医院糖尿病配方的平均血浆葡萄糖显著更低(122±26.25 vs. 144.68±36.91mg/dL,p = 0.022)、成本更低(550.1±33.57 vs. 797.81±42.29泰铢,p = 0.004)以及毛细血管血糖检测次数更少(5±0.94 vs. 5.3±0.82次,p = 0.083),但MAGE水平无显著差异(5.86±2.78 vs. 7.71±4.34mg/dL,p = 0.333)。

结论

诗里蒙坤贴医院糖尿病配方的平均血浆葡萄糖显著更低,毛细血管血糖检测次数更少,且比市售糖尿病配方成本更低。诗里蒙坤贴医院糖尿病配方的血糖变异性(MAGE)也低于市售糖尿病配方,但未达到统计学显著性。两种配方的血浆葡萄糖水平均低于180mg/dL。

相似文献

1
Comparative study between the Phramongkutklao's diabetic blenderized diets and commercial diabetic diets on glycemic variability in continuous tube fed patients with type 2 diabetes.帕罗蒙库特科劳医院糖尿病混合饮食与市售糖尿病饮食对2型糖尿病持续管饲患者血糖变异性的比较研究。
J Med Assoc Thai. 2014 Nov;97(11):1151-6.
2
A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes.一种针对糖尿病的肠内配方可改善 2 型糖尿病患者的血糖变异性。
Diabetes Technol Ther. 2010 Jun;12(6):419-25. doi: 10.1089/dia.2009.0185.
3
Use of a Low-carbohydrate Enteral Nutrition Formula with Effective Inhibition of Hypoglycemia and Post-infusion Hyperglycemia in Non-diabetic Patients Fed via a Jejunostomy Tube.在通过空肠造口管喂养的非糖尿病患者中使用低血糖和输注后高血糖有效抑制的低碳水化合物肠内营养配方。
Intern Med. 2020 Aug 1;59(15):1803-1809. doi: 10.2169/internalmedicine.4465-20. Epub 2020 May 26.
4
Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study.糖尿病专用肠内营养配方在高血糖、机械通气的危重症患者中的应用:一项前瞻性、开放标签、盲法随机、多中心研究。
Crit Care. 2015 Nov 9;19:390. doi: 10.1186/s13054-015-1108-1.
5
The comparative study of diabetic specific formula and standard formula on postprandial plasma glucose control in type 2 DM patients.糖尿病专用配方与标准配方对2型糖尿病患者餐后血糖控制的对比研究。
J Med Assoc Thai. 2014 Jun;97(6):582-8.
6
Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.阿卡波糖对接受稳定基础治疗但血糖控制不佳的2型糖尿病患者血糖变异性的影响:一项安慰剂对照试验。
Pharmacotherapy. 2015 Nov;35(11):983-90. doi: 10.1002/phar.1648. Epub 2015 Nov 2.
7
[Blood glucose and insulin responses to two hypocaloric enteral formulas in patients with diabetes mellitus type 2].
Nutr Hosp. 2013 May-Jun;28(3):600-96. doi: 10.3305/nh.2013.28.3.6432.
8
Starch digestibility modulation significantly improves glycemic variability in type 2 diabetic subjects: A pilot study.淀粉消化率调节显著改善 2 型糖尿病患者的血糖变异性:一项初步研究。
Nutr Metab Cardiovasc Dis. 2021 Jan 4;31(1):237-246. doi: 10.1016/j.numecd.2020.08.010. Epub 2020 Aug 25.
9
Beneficial effects of a diabetes specific formula on insulin sensitivity and free fatty acid in patients with type 2 diabetes mellitus.一种糖尿病专用配方对2型糖尿病患者胰岛素敏感性和游离脂肪酸的有益作用。
Chin Med J (Engl). 2008 Apr 20;121(8):691-5.
10
Very high-protein and low-carbohydrate enteral nutrition formula and plasma glucose control in adults with type 2 diabetes mellitus: a randomized crossover trial.高蛋白低碳水化合物肠内营养配方与 2 型糖尿病成人患者的血糖控制:一项随机交叉试验。
Nutr Diabetes. 2018 Aug 30;8(1):45. doi: 10.1038/s41387-018-0053-x.

引用本文的文献

1
An Evaluation of the Nutritional Value and Physical Properties of Blenderised Enteral Nutrition Formula: A Systematic Review and Meta-Analysis.搅拌机肠内营养配方的营养价值和物理性质评估:系统评价和荟萃分析。
Nutrients. 2020 Jun 20;12(6):1840. doi: 10.3390/nu12061840.
2
Management of Glucose Control in Noncritically Ill, Hospitalized Patients Receiving Parenteral and/or Enteral Nutrition: A Systematic Review.接受肠外和/或肠内营养的非危重症住院患者的血糖控制管理:一项系统评价
J Clin Med. 2019 Jun 28;8(7):935. doi: 10.3390/jcm8070935.
3
A Survey of Home Enteral Nutrition Practices and Reimbursement in the Asia Pacific Region.
亚太地区家庭肠内营养实践与报销情况调查。
Nutrients. 2018 Feb 14;10(2):214. doi: 10.3390/nu10020214.